Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 68084-313

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68084-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp31301

Divalproex Sodium 125 mg capsule, coated pellets, shown with a distinctive two-tone blue and white design. The capsule is marked with partial black printed text including the dose strength and identification codes. The image shows the capsule dosage form clearly, consistent with oral administration.*

FDA Label Image

Stuctural Formula (Structure)

Chemical structure of divalproex sodium showing the polymeric form with sodium ions and multiple valproic acid units linked.*

FDA Label Image

Figure 1 (Figure 1)

A cumulative distribution plot showing the percentage reduction in CPS rate for patients treated with Divalproex Sodium Delayed-release Tablets compared to placebo. The x-axis represents the percentage of patients, while the y-axis shows the percentage reduction in CPS rate. The graph compares treatment improvement and worsening between the two groups.*

FDA Label Image

Figure 2 (Figure 2)

A line chart showing the percent reduction in CPS Rate plotted against the percent of patients, with two lines comparing High Dose (solid line) and Low Dose (dashed line). The chart includes labels indicating 'Improvement' above and 'Worsening' below, with a 'No Change' line at 0% reduction.*

FDA Label Image

Instructions For Use (Row 2 Image)

Divalproex Sodium 125 mg coated pellets capsule shown between fingers, indicating the oral dosage form and strength. The capsule is white with legible text displaying the active ingredient and strength. Labeler indicated as American Health Packaging.*

FDA Label Image

Instructions For Use (Row 3 Image)

An illustration showing a coated pellet capsule labeled Divalproex Sodium, positioned near an anatomical bone structure, likely indicating oral administration and targeting bone or joint areas.*

FDA Label Image

Instructions For Use (Row 4 Image)

Illustration showing a hand opening a capsule filled with coated pellets, with the pellets being sprinkled out onto a surface. The image demonstrates the form of Divalproex Sodium as coated pellet capsules intended for oral administration.*

FDA Label Image

Instructions For Use (Row 5 Image)

An illustration showing a person with their mouth open, about to take a dose of medication from a spoon. The image visually represents oral administration of a drug.*

FDA Label Image

125 mg Divalproex Sodium Delayed-release Capsules Carton-50ud (125 mg Divalproex Sodium Delayed Release Capsules Carton 50ud)

Divalproex Sodium 125 mg delayed-release capsules label from American Health Packaging. The label shows the product name, strength, dosage form containing coated pellets, and package quantity of 50 capsules (5 x 10). It includes storage instructions, usage guidance, and a barcode along with a QR code for medication guide and prescribing information.*

FDA Label Image

125 mg Divalproex Sodium Delayed-release Capsules Carrton-100ud (125 mg Divalproex Sodium Delayed Release Capsules Carrton 100ud)

Divalproex Sodium Delayed-Release Capsules, USP, 125 mg (Valproic Acid Activity) label. The package contains 100 capsules (10 x 10) distributed by American Health Packaging, Columbus, Ohio. The label includes storage instructions, usage notes, and a QR code for current Medication Guide and Prescribing Information. The product is Rx Only.*

FDA Label Image

125 mg Divalproex Sodium Delayed-release Capsule Blister (125 mg Divalproex Sodium Delayed Release Capsule Blister)

Labels for Divalproex Sodium 125 mg delayed-release capsules, containing coated pellets. Each label displays the proprietary and generic name, strength, route as oral, with barcode and space for lot number and expiration date. The labeler is American Health Packaging, Columbus, Ohio. Product NDC is 68084-313.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.